Abstract
Background: Fetuin A is an inhibitor of insulin action and have been found to be related with subcutaneous lipid accumulation and insulin resistance. The relation of cardiac lipid accumulation, fetuin A and insulin resistance parameters in obese children is not well-known. The aim of the study was to evaluate the relation of serum fetuin A levels with subcutaneous and cardiac lipid accumulation, and insulin resistance parameters in Turkish obese children.
Methods: Serum fetuin A levels, cardiac and subcutaneous lipid accumulation parameters of 42 obese (10.9±2.3 years, 19 female) and 40 control group subjects (11.2±2.7) were compared. Cardiac lipid accumulation measured by subepicardial adipose tissue thickness. Insulin resistance was assessed using homeostasis model assessment (HOMA-IR) index.
Results: There were significant correlations serum fetuin A levels with BMI-SDS, circumferences of waist, hip and midarm, SATT and HOMA-IR (r=0.362, p=0.018, r=0.728, p=0.001, r=0.662, p=0.0001, r=0.713, p=0.0001, r=0.477, p=0.001, and r=0.330, p=0.038 as, respectively).
Conclusions: Fetuin A was correlated well with cardiac and subcutaneous lipid accumulation, insulin resistance parameters, which may be related with early pathogenetic mechanisms of metabolic obesity complications in children.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Sypniewska G. Laboratory assessment of cardiometabolic risk in overweight and obese children. Clin Biochem 2015;48:370–6.10.1016/j.clinbiochem.2014.12.024Search in Google Scholar
2. Masarone M, Federico A, Abenavoli L, Loguercio C, Persico M. Non alcoholic fatty liver. Epidemiology and Natural History. Rev Recent Clin Trials 2014;9:126–33.10.2174/1574887109666141216111143Search in Google Scholar
3. Pacifico L, Nobili V, Anania C, Verdecchia P, Chiesa C. Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. World J Gastroenterol 2011;17:3082–91.Search in Google Scholar
4. Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003;143:500–5.10.1067/S0022-3476(03)00325-1Search in Google Scholar
5. Atabek ME. Diagnosis of nonalcoholic fatty liver disease in obese children. J Pediatric Endocrinol Metab 2012;25:613.10.1515/jpem-2012-0072Search in Google Scholar PubMed
6. Patton HM, Yates K, Unalp-Arida A, Behling CA, Huang TT, et al. Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease. Am J Gastroenterol 2010;105:2093–102.10.1038/ajg.2010.152Search in Google Scholar PubMed PubMed Central
7. Srinivas PR, Wagner AS, Reddy LV, Deutsch DD, Leon MA, et al. Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol 1993;7:1445–55.Search in Google Scholar
8. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, et al. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006;29:853–7.10.2337/diacare.29.04.06.dc05-1938Search in Google Scholar PubMed
9. Trepanowski JF, Mey J, Varady KA. Fetuin-A: a novel link between obesity and related complications. Int J Obes (Lond) 2015;39:734–41.10.1038/ijo.2014.203Search in Google Scholar PubMed
10. Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, et al. Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 2008;118:2555–62.10.1161/CIRCULATIONAHA.108.814418Search in Google Scholar PubMed
11. Mori K, Emoto M, Araki T, Yokoyama H, Teramura M, et al. Association of serum fetuin-A with carotid arterial stiffness. Clin Endocrinol (Oxf) 2007;66:246–50.10.1111/j.1365-2265.2006.02716.xSearch in Google Scholar PubMed
12. Jialal I, Devaraj S, Hennige AM, Staiger H, Wicke C, et al. Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One 2008;3:1.Search in Google Scholar
13. Bettaieb A, Haj F, Adams-Huet B. Increased adipose tissue secretion of Fetuin-A, lipopolysaccharide-binding protein and high-mobility group box protein 1 in metabolic syndrome. Atherosclerosis 2015;241:130–7.10.1016/j.atherosclerosis.2015.04.814Search in Google Scholar PubMed
14. Mukhopadhyay S, Mondal SA, Kumar M, Dutta D. Proinflammatory and antiinflammatory attributes of fetuin-a: a novel hepatokine modulating cardiovascular and glycemic outcomes in metabolic syndrome. Endocr Pract 2014;20:1345–51.10.4158/EP14421.RASearch in Google Scholar PubMed
15. Ismail NA, Ragab S, El Dayem SM, Elbaky AA, Salah N, et al. Fetuin-A levels in obesity: differences in relation to metabolic syndrome and correlation with clinical and laboratory variables. Arch Med Sci 2012;8:826–33.10.5114/aoms.2012.31616Search in Google Scholar PubMed PubMed Central
16. Lebensztejn DM, Białokoz-Kalinowska I, Kłusek-Oksiuta M, Tarasów E, Wojtkowska M, et al. Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease. Adv Med Sci 2014;59:81–4.10.1016/j.advms.2013.08.003Search in Google Scholar PubMed
17. Reinehr T, Roth CL. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab 2008;93:4479–85.10.1210/jc.2008-1505Search in Google Scholar PubMed
18. Malin SK, del Rincon JP, Huang H, Kirwan JP. Exercise-induced lowering of fetuin-A may increase hepatic insulin sensitivity. Med Sci Sports Exerc 2014;46:2085–90.10.1249/MSS.0000000000000338Search in Google Scholar PubMed PubMed Central
19. Preis SR, Massaro JM, Robins SJ, Hoffmann U, Vasan RS, et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring) 2010;18:2191–8.10.1038/oby.2010.59Search in Google Scholar PubMed PubMed Central
20. Fluchter S, Haghi D, Dinter D, Heberlein W, Kühl HP, et al. Volumetric assessment of epicardial adipose tissue with cardiovascular magnetic resonance imaging. Obesity (Silver Spring) 2007;15:870–8.10.1038/oby.2007.591Search in Google Scholar PubMed
21. Hızlı S, Ozdemir O, Abacı A, Razi CH, Kabakuş N. Relation of subepicardial adipose tissue thickness and clinical and metabolic parameters in obese prepubertal children. Pediatr Diabetes 2010;11:556–62.10.1111/j.1399-5448.2010.00644.xSearch in Google Scholar PubMed
22. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, et al. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 2007;85:660–7.10.2471/BLT.07.043497Search in Google Scholar PubMed PubMed Central
23. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005;115:e500–3.10.1542/peds.2004-1921Search in Google Scholar PubMed
24. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555–76.10.1542/peds.114.S2.555Search in Google Scholar
25. Demircioğlu F, Koçyiğit A, Arslan N, Cakmakçi H, Hizli S, et al. Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2008;47:68–75.10.1097/MPG.0b013e31816232c9Search in Google Scholar PubMed
26. Dahlman I, Eriksson P, Kaaman M, Jiao H, Lindgren CM, et al. Alpha2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action. Diabetologia 2004;47:1974–9.10.1007/s00125-004-1556-7Search in Google Scholar PubMed
27. Hizli S, Koçyigit A, Arslan N, Tuncel SA, Demircioglu F, et al. Hepatic artery resistance in children with obesity and fatty liver. Indian J Pediatr 2010;77:407–11.10.1007/s12098-010-0045-xSearch in Google Scholar PubMed
©2016 by De Gruyter
